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ABSTRACT	Learned	associations	about	salient	experiences	(e.g.	drug	exposure,	stress)	and	
their	associated	environmental	stimuli	are	mediated	by	a	minority	of	sparsely	distributed,	
behaviorally	activated	neurons	coined	‘neuronal	ensembles’.	For	many	years,	it	was	not	
known	whether	these	neuronal	ensembles	played	causal	roles	in	mediating	learned	
behaviors.	However,	in	the	last	several	years	the	‘Daun02	inactivation	technique’	in	Fos-lacZ	
transgenic	rats	has	proved	very	useful	in	establishing	causal	links	between	neuronal	
ensembles	that	express	the	activity-regulated	protein	‘Fos’	and	learned	behaviors.	Fos-
expressing	neurons	in	these	rats	also	express	the	bacterial	protein	b-galactosidase	(b-gal)	in	
strongly	activated	neurons.	When	the	prodrug	Daun02	is	injected	into	the	brains	of	these	
rats	90	min	after	a	behavior	(e.g.	drug-seeking)	or	cue	exposure,	then	the	Daun02	is	
converted	into	daunorubicin	by	b-gal,	which	selectively	inactivates	the	Fos	and	b-gal-
expressing	neurons	that	were	activated	90	min	before	the	Daun02	injection.	This	unit	
presents	protocols	for	breeding	the	Fos-lacZ	rats	and	conducting	appropriate	Daun02	
inactivation	experiments.			
Significance	Statement	
Learned	behaviors	are	mediated	by	specific	patterns	of	sparsely	distributed	neurons,	called	
‘neuronal	ensembles’,	that	are	selectively	activated	during	behavior	and	cue	exposures.	For	
many	years,	neuroscientists	observed	that	neural	activity	of	specific	neurons	correlated	with	
specific	behaviors	or	cue	exposures.	However,	they	could	not	determine	whether	these	
selectively	activated	neurons	play	‘causal	roles’	in	the	learned	behaviors	because	tools	to	
selectively	silence	only	the	behaviorally	activated	neurons	without	affecting	the	surrounding	
neurons	were	unavailable.	The	Daun02	inactivation	technique	described	in	this	protocol	
selectively	inactivates	neurons	that	were	activated	strongly	enough	during	recent	behavior	
to	express	the	proteins	b-galactosidase	(b-gal)	in	Fos-lacZ	transgenic	rats.	Researchers	use	
this	tool	to	establish	whether	specific	neuronal	ensembles	directly	mediate	learned	
behaviors.		
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INTRODUCTION	For	many	decades,	neuroscientists	have	been	deciphering	the	
neurobiological	basis	of	learned	behaviors	by	mapping	the	activity	patterns	of	neurons.	
Early	studies	from	the	1970’s	using	in	vivo	electrophysiology	tools	have	observed	that	only	a	
minority	of	neurons	were	activated	during	learned	behaviors	(John	and	Schwartz,	1978;	
Umemoto	and	Olds,	1975).	Around	the	1980-90’s,	researchers	complemented	these	
electrophysiology	findings	using	immediate	early	gene	(IEG)	markers	of	strong	neuronal	
activity	(Guzowski,	2002;	Herdegen	and	Leah,	1998;	Morgan	and	Curran,	1988;	Morgan	and	
Curran,	1991).	Fos	mRNA	and	its	protein	product	Fos	(Morgan	and	Curran,	1988;	Morgan	
and	Curran,	1991),	a	commonly	used	IEG	marker,	have	been	used	to	perform	large-scale	
activity	mapping	of	many	brain	areas	in	behavior.	Today,	it	is	known	that	various	stimuli	
induce	Fos	in	motivationally	relevant	brain	areas,	including	the	prefrontal	cortex	and	
nucleus	accumbens	(Cruz	et	al.,	2014b).	These	stimuli	range	from	stressful	stimuli,	drugs	of	
abuse	(e.g.	cocaine),	ingestion	of	palatable	foods,	and	cues	associated	with	drug	and	natural	
rewards	(Cruz	et	al.,	2013).	Although	interesting,	these	findings	were	purely	correlative	and	
did	not	demonstrate	whether	these	activated	neurons	played	a	direct	causal	role	in	the	
learned	behaviors.	Until	recently,	tools	did	not	exist	to	selectively	silence	the	small	number	
of	activated	neurons	without	disrupting	activity	of	the	surrounding	majority	of	neurons.		
To	overcome	this	challenge,	we	developed	a	tool,	coined	the	‘Daun02	inactivation	
procedure’,	to	selectively	silence	Fos-expressing	neurons	(Fig.	1)	and	demonstrate	a	causal	
for	Fos-expressing	ensembles	in	a	behavior	(Koya	et	al.,	2009).	In	this	inactivation	
procedure,	Fos-lacZ	transgenic	rats	undergo	some	form	of	learning,	and	then	are	exposed	to	
external	stimuli	(e.g.	reward-related	cues)	that	reactivate	a	neuronal	ensemble	and	induce	
expression	of	the	activity-dependent	transgene	lacZ	and	its	protein	product	β-gal	in	the	
activated	Fos-expressing	neurons	(Bossert	et	al.,	2011;	Koya	et	al.,	2009).	When	β-gal	levels	
are	maximal,	the	inactive	prodrug	Daun02	(Farquhar	et	al.,	2002)	is	injected	directly	into	the	
brain	area	of	interest.	Daun02	is	converted	by	β-gal	into	daunorubicin	to	reduce	cellular	
excitability	(Engeln	et	al.,	2014)	and	induce	apoptosis	and	cell	death	(Pfarr	et	al.,	2015).	
Thus,	activated	β-gal	expressing	neurons	are	selectively	and	persistently	silenced,	while	the	
surrounding	neurons	are	unaffected.	The	behavioral	consequences	of	inactivating	the	
Fos/β-gal-expressing	neuronal	ensembles	can	then	be	examined.	
This	unit	describes	the	Daun02	inactivation	procedure	that	allows	inactivation	of	
behaviorally-activated	β-gal	(and	Fos)-expressing	neurons	in	Fos-lacZ	rats.	Although	Fos-lacZ	
mice	that	express	β-gal	in	activated	neurons	have	also	been	generated	(Smeyne	et	al.,	
1992),	our	focus	here	will	be	on	the	Fos-lacZ	rat,	since	to	date	there	are	no	published	
studies	that	use	Daun02	inactivation	in	these	mice.		There	are	multiple	Basic	Protocols	in	
this	unit	with	several	key	steps	described	in	each	Protocol,	and	they	are	written	in	the	order	
of	the	events	you	will	encounter	from	start	to	finish.	Figure	2	provides	a	general	overview	of	
the	major	steps.		
Note:	All	protocols	using	live	animals	must	be	reviewed	first	by	institutional	ethical	
committees	(and/or	any	other	government	regulatory	agencies	in	your	country)	and	must	
follow	officially	approved	procedures	for	care	and	use	of	laboratory	animals.		
BASIC	PROTOCOL	1	
Breeding	and	genotyping	of	Fos-lacZ	transgenic	rats		
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Fos-lacZ	rats	are	bred	on	a	Sprague-Dawley	background.	Use	only	hemizygous	Fos-lacZ	rats.	
We	found	that	homozygous	Fos-lacZ	rats	express	higher	basal	levels	of	b-gal	that	will	
interfere	with	selective	Daun02	inactivation	of	only	the	behaviorally-activated	neurons	
(unpublished	observations).	An	animal	hemizygous	for	the	Fos-lacZ	gene	(male	or	female)	
should	be	mated	with	an	outbred	wild-type	animal	(male	or	female).	Approximately	50%	of	
the	offspring	will	be	transgene-positive.	As	a	general	rule	of	thumb,	11-12	breeding	pairs	
will	produce	approximately	28-32	positive	male	and	female	offspring	per	month.	Ear	
punches	or	tail	snips	can	be	used	for	genotyping.	The	PCR	protocol,	including	specific	primer	
sets,	for	detecting	the	Fos-lacZ	gene	is	provided	below,	but	the	protocol	can	be	modified	
depending	on	the	primer	set.	
Materials		
Ear	punch	collector	(for	ear	punches)	(Cat	no.	24212-02,	Fine	Science	Tools)		
Local	(e.g.	lidocaine	cream)	or	general	anesthetic	(e.g.	isoflurane)	(for	tail	tip	removal)		
Sterile	blade	or	scissors		
1.5mL	microfuge	tubes	
Vortex	device	
Sodium	hydroxide	solution	10.0M	(Cat	no.	72068-100ML,	Sigma)	
Trizma®	hydrochloride	solution	1M	(Tris-HCl)	pH	8	(Cat	no.,	T2694-1L,	Sigma)	
	OneTaq	DNA	polymerase	Mastermix	(Cat	no.	M0482S,	New	England	Biolabs)	
Oligos	(IDT	DNA	Technologies,	standard	synthesis,	and	desalting	preparation)		
PCR	primers	forward	sequence:	GTTGCAGTGCACGGCAGATACACTTGCTGA	;	reverse	sequence	
GCCACTGGTGTGGGCCATAATTCAATTCGC	
100bp	DNA	ladder	(Cat	no.	N3231S,	New	England	Biolabs)	
Ultra	pure	10x	TAE	buffer	(Cat	no.	15558-026,	ThermoFisher	Scientific)	
Agarose	(for	DNA	gel	electrophoresis)	
Ethidium	bromide	
Sub-Cell®	Model	96	Cell	and	PowerPac™	Universal	Power	Supply	(Bio-rad)	or	equivalent	
Protocol	steps		
1.	Obtain	tissue	samples	for	genotyping.	For	ear	punches,	gently	restrain	the	rat	and	remove	
a	punch	using	an	ear	punch	collector.		A	tail	sample	from	the	rat	may	also	be	removed	for	
genotyping	purposes,	but	this	procedure	is	more	invasive	and	it	will	require	the	appropriate	
local	or	general	anesthetic	if	the	rat	is	more	than	3.5	weeks	old.	Clean	the	tail	with	alcohol	
first	and	use	a	sterile	blade	or	scissors	to	remove	the	distal	2-4	mm	portion	of	the	tail.	
Remember	to	disinfect	the	blade	or	scissors	(e.g.	using	hot	beads)	between	rats.	Mild	
anesthesia	(e.g.	isoflurane)	can	be	used	for	either	ear	punches	or	tail	samples.	Place	the	
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biopsy	sample	in	a	1.5ml	microfuge	tube.	After	the	rat	is	returned	to	the	cage,	monitor	the	
rat	and	use	appropriate	cauterizing	agents	(e.g.	silver	nitrate)	for	hemostasis	if	necessary.	
More	information	can	be	found	here:	
http://oacu.od.nih.gov/ARAC/documents/Rodent_Genotyping.pdf	
2.	Add	300	µL	of	50mM	NaOH.	
3.	Incubate	tubes	at	95ºC	for	60	minutes.	
4.	Vortex	tubes	on	medium	power	setting	for	5	seconds.	
5.	Quick	spin	the	tubes	to	bring	down	the	condensation.	
6.	Neutralize	each	sample	by	adding	30	µL	of	1M	Tris-HCl	(pH	8).	
7.	Vortex	tubes	on	medium	power	setting	for	5	seconds.	
8.	Quick	spin	the	tubes	to	bring	down	the	condensation.	The	undigested	remnant	of	the	
sample	or	debris	may	remain	visible	at	the	bottom	of	the	tube.	Some	debris	is	to	be	
expected,	and	make	sure	to	only	take	the	supernatant	(what	we	refer	to	as	‘genomic	DNA	
lysate’)	when	setting	up	the	PCR	reaction.		
9.	Add	1µL	of	genomic	DNA	lysate	to	the	PCR	‘master	mix’	(see	Reagents	and	Solutions	
section).		
10.	For	the	PCR	reaction	use	the	following	reaction	conditions:		
	 0.	94	ºC	–	HOLD	(hot	start)	
1.	94	ºC	–	2	min	
2.	94	ºC	–	30	sec	
3.	68	ºC	–	1	min	
4.		Go	to	step	2,	repeat	40x	
5.		4	ºC	–	HOLD	(end	of	program)	
11.	Analyze	the	PCR	reaction	products	by	electrophoresis	in	a	2%	agarose	gel	in	1x	TAE	
buffer.	The	addition	of	0.5	µg	of	ethidium	bromide	per	1	mL	of	agarose	solution	will	indicate	
the	position	of	the	PCR	products.		
	
BASIC	PROTOCOL	2		
Preparation	of	Daun02		
Daun02	(MW	884.79)	is	an	anthracyline-based	‘prodrug’	that	is	initially	biologically	inactive.	
Daun02	becomes	biologically	active	when	it	is	converted	into	daunorubicin	(also	known	as	
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daunomycin)	by	the	bacterial	protein	b-gal.	In	the	first	study,	Daun02	was	solubilized	in	50%	
DMSO	and	50%	artificial	cerebrospinal	fluid	(aCSF),	which	worked	well	for	nucleus	
accumbens	injections	(Koya	et	al.,	2009).	For	reasons	unknown,	this	vehicle	produces	more	
neuronal	damage	in	cortical	areas,	and	thus	we	and	others	routinely	use	4	µg/µL	Daun02	in	
5%	DMSO	and	6%	Tween-80	in	PBS,	which	can	be	prepared	using	the	protocol	below.		
Note:	The	Daun02	compound	is	available	from	several	manufacturers	and	should	be	stored	
at	-20	ºC	in	a	sealed	container	with	desiccant.	As	with	all	anthracyline-related	compounds,	it	
should	be	handled	in	a	well-ventilated	area	using	appropriate	safety	measures	(e.g.	gloves).	
Also,	when	dissolving	Daun02	make	sure	to	use	containers	using	DMSO	compatible	material	
(e.g.	LDPE,	HDPE,	polypropylene,	PPCO,	polymethylpentene)	that	tend	to	have	an	opaque	
colour,	as	non-compatible	materials	(e.g.	polysulfone,	PVC,	polycarbonate)	with	a	clear	
appearance,	will	be	dissolved	by	DMSO.			
Materials		
Daun02	(Cat	no.	SRP04000g;	Sequoia	Research	Products)	
Dimethyl	sulfoxide	(DMSO)	(Cat	no.	D8418-50mL,	Sigma)	
Tween-80	(Cat	no.	P4780-100mL,	Sigma)	
10x	Phosphate	buffered	saline	(PBS)	(Cat	no.	P5493-1L,	Sigma)		
Artificial	cerebral	spinal	fluid	(aCSF)	(Cat	No.	3525,	Tocris)	
1. Dissolve	Daun02	in	100%	DMSO	in	a	microfuge	tube	at	a	concentration	of	80	µg/µL	
by	gently	pipetting	up	and	down,	followed	by	vortexing.	This	stock	solution	may	be	
stored	at	-20ºC	for	up	to	1	year	(or	at	-80ºC	for	several	years).		
2. On	the	day	of	use,	fully	thaw	the	frozen	aliquot	to	room	temperature	or	if	freshly	
prepared,	directly	dissolve	2.5	µL	of	80	µg/µL	Daun02	in	DMSO	(or	2.5	µL	DMSO	to	
make	vehicle)	for	every	15	µL	of	20%	Tween-80.	Make	9	µL	aliquots	and	store	at	-
20ºC	for	up	to	1	year	or	-80ºC	for	several	years.		
3. On	the	day	of	use,	fully	thaw	frozen	Daun02	(or	vehicle)	aliquot	to	room	
temperature.	Then	add	16.5	µL	of	sterile	PBS	or	aCSF	and	mix	well	to	make	a	4	µg/µL	
Daun02	solution	in	5%	DMSO,	6%	Tween-80	vehicle.		
NOTE:	Daun02	will	precipitate	irreversibly	if	PBS	or	aCSF	is	added	before	the	Daun02	
stock	solution	has	warmed	to	room	temperature.	It	is	important	to	make	the	vehicle	
control	for	injections	using	the	same	solution.		
4. Quick	spin	both	the	Daun02	and	vehicle	to	bring	solution	to	the	bottom	of	the	
microfuge	tube.	Keep	this	solution	at	room	temperature	until	use,	and	discard	the	
remaining	solution.		
BASIC	PROTOCOL	3	
Surgical	procedures	for	guide	cannula	implantation	for	rat	
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In	order	to	exert	its	neuronal	inactivation	functions	in	a	region-specific	manner,	Daun02	
must	be	directly	injected	into	the	target	brain	areas,	since	anthracycline-related	compounds	
do	not	effectively	cross	the	blood-brain	barrier	(Rousselle	et	al.,	2000).	Thus,	Fos-lacZ	rats	
must	be	intracranially	implanted	with	guide	cannula	prior	to	Daun02	infusions.	This	protocol	
describes	this	cannula	implantation.	For	a	useful	video	guide,	please	see	(Fornari	et	al.,	
2012).		
Materials	
Any	anesthesia	(e.g.	isoflurane/air	mixture	or	ketamine	and	xylazine)	that	will	last	for	the	
duration	of	surgery	(approximately	1	hour).		
Atropine	sulfate	
Betadine	disinfectant		
70%	ethanol		
Dental	acrylic	(Plastics	one)	
Stereotaxic	atlas	for	rat	
Stereotaxic	frame	equipped	with	carrier	for	guide	cannula	(David	Kopf	Instruments,	
Stoelting)	
26-G	internal	cannula	(Plastics	one)		
Shaver		
Scalpel	
Serrefine	forceps	or	hemostats	
Cotton	Swabs	
Dental	cotton	rolls		
Metal	Spatula		
Dental	drill	
Bone	screws:	4.8mm	shaft	length,	2.5mm	head	diameter,	1.57mm	shaft	diameter	(PART#	0-
80	x	3/16;	Plastics	One)	
Jeweler’s	forceps	and	screwdriver	
Protocol	steps	
1. Using	a	stereotaxic	brain	atlas	such	as	(Paxinos,	1986)	to	determine	the	stereotaxic	
coordinates	for	the	target	brain	areas.	Make	sure	to	order	or	make	the	correct	
lengths	of	guide	cannulas	and	injector	needles,	so	that	the	needles	protrude	0.5-1	
mm	beyond	the	tip	of	the	guide	cannulas.	This	protrusion	ensures	that	the	Daun02	is	
properly	delivered	to	the	target	area.	A	commonly	used	landmark	on	the	skull	is	the	
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‘bregma’	where	the	major	fissures	of	the	skull	form	a	plus-like	symbol.	This	
examination	should	be	done	after	the	anesthetized	animal	has	been	inserted	into	
the	stereotaxic	frame.	Pilot	studies	are	highly	recommended	for	accurate	guide	
cannula	placement	since	the	actual	injection	sites	may	differ	from	the	‘intended’	
sites.		
2. Make	sure	to	sterilize	all	surgical	instruments	via	autoclaving	or	chemical	
sterilization.	Continue	to	use	aseptic	conditions	during	surgeries.	
3. Once	the	rat	is	properly	restrained,	inject	it	with	an	anesthetic	that	will	last	for	the	
duration	of	surgery	(e.g.	intraperitoneal	injections	of	ketamine	and	xylazine	or	
inhaled	isoflurane/air	mixture).	If	necessary,	administer	atropine	to	relieve	
respiratory	distress.	The	efficacy	of	the	anesthesia	should	be	monitored	by	observing	
the	breathing	(which	should	mostly	be	abdominal)	and	test	for	pain	reflexes	by	
pinching	on	of	the	feet	with	forceps	or	using	your	fingers.	If	a	response	is	observed	
after	10	min,	a	supplemental	dose	of	anesthetic	should	be	administered.	
4. Shave	the	fur	off	the	rat’s	head	until	the	surface	is	smooth.	After	checking	again	that	
the	rat	is	deeply	anesthetized	and	there	is	no	pain	reflex	(e.g.	following	pinching	the	
rear	foot),	mount	the	rat	in	the	ear	bars	of	the	stereotaxic	apparatus.	Read	the	
coordinates	of	each	ear	bar	and	center	the	animal	between	the	bars.	Open	the	rat’s	
mouth	and	insert	the	upper	incisors	over	the	incisor	bar.	Adjust	the	nose	clamp	to	
firmly	hold	the	rat’s	head.		
5. Disinfect	the	head	using	Betadine,	followed	by	70%	ethanol,	and	then	Betadine	
again.	Make	an	incision	around	the	midline	of	the	head	using	a	scalpel	using	one	
smooth	stroke.	Then	retract	the	skin	using	hemostats	or	Serrafine	forceps.		
6. Expose	the	skull,	by	first	making	an	incision	using	a	sterile	scalpel	and	scrape	off	the	
dura	matter	using	a	metal	spatula.	Clean	off	any	excess	blood	using	cotton	swabs	or	
dental	cotton	rolls.	Lower	the	guide	cannula	so	that	it	is	centered	on	the	bregma,	
which	is	the	intersection	of	the	coronal	and	sagittal	sutures.	Read	the	anterior-
posterior	(AP),	lateral	(L),	and	dorsal-ventral	(DV)	coordinates	from	the	scale,	and	
add	or	subtract	from	the	bregma	coordinates	to	calculate	the	relative	coordinates	
for	the	intended	injection	site.		
7. Move	the	guide	cannula	to	the	intended	anterior-posterior	and	lateral	coordinates	
on	the	skull	surface	to	identify	the	drilling	sites.	You	may	use	a	fine-tipped	felt	pen	to	
mark	the	drilling	point.	Then	raise	the	stereotaxic	arms	so	that	the	skull	may	be	
drilled.		
Implantation	of	the	guide	cannula	
8. Drill	two	holes	bilaterally	into	the	skull	where	the	guide	cannulae	are	to	be	inserted.	
Use	a	hand	drill	with	a	drill	bit	slightly	larger	than	the	diameter	of	the	guide	cannula.	
Drill	four	more	small	holes	for	bone	screws	with	two	holes	in	each	of	the	parietal	and	
frontal	bones	of	the	left	and	right	hemispheres.	Make	sure	that	these	holes	are	not	
too	close	to	the	guide	cannula	holes	and	do	not	drill	through	the	skull	fissures.	Drill	
slowly	and	carefully	until	the	dura	is	broken,	but	do	not	damage	the	brain	tissue	by	
drilling	too	deep.	
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9. Using	jeweler’s	forceps	and	a	screwdriver,	insert	the	3/16-inch	bone	screws	into	the	
four	smaller	holes.		
10. Attach	the	guide	cannula	into	the	stereotaxic	holder	and	straighten.	Carefully	lower	
the	guide	cannula	into	the	target	area	until	the	cannula	base	rests	on	the	skull.		
11. Dry	the	skull	again	if	necessary	and	remove	the	skin	retractors.	It	is	important	that	
the	skull	is	dry	in	order	for	the	dental	cement	to	adhere	to	the	skull.	Mix	dental	
acrylic	and	liquid	component	until	the	mixture	is	wet.	While	it	is	wet,	apply	this	
mixture	to	the	skull	around	the	base	of	the	guide	cannula	and	screws.		
12. Once	the	acrylic	is	dry,	remove	the	stereotaxic	holder.	If	there	are	any	jagged	edges,	
make	sure	to	smooth	them	out	by	applying	additional	dental	acrylic	mixture.	These	
jagged	edges	will	irritate	the	rat.	
13. Remove	the	rat	from	the	stereotaxic	holder,	and	implant	a	dummy	cannula	into	the	
guide	cannula.	Allow	the	rat	to	rest	in	its	home	cage	and	use	a	heating	blanket	and	
thermometer	to	maintain	proper	body	temperature.		
14. The	rats	should	be	allowed	to	recover	for	7	days	(or	longer	if	necessary)	before	
commencing	any	behavioral	experiments.	Make	sure	to	unblock	the	guide	cannula	
for	debris	every	2	days	by	repeatedly	inserting	the	dummy	cannula	up	and	down.		
BASIC	PROTOCOL	4	
Intracranial	infusions	of	Daun02	and	subsequent	behavioral	testing	
Behavioral	training	may	commence	approximately	a	week	after	surgery.	Many	Daun02	
studies	to	date	have	silenced	neurons	that	were	activated	during	different	motivated	
behaviors	on	‘induction	day’,	and	then	tested	3	days	later	to	observe	whether	the	behavior	
of	interest	was	disrupted	(Bossert	et	al.,	2011;	Cruz	et	al.,	2014a;	Fanous	et	al.,	2012;	Koya	
et	al.,	2009).	On	induction	day,	we	reactivate	a	specific	neuronal	ensemble	by	exposing	the	
rat	to	cues	associated	with	the	learned	behavior,	with	or	without	performance	of	the	actual	
behavior,	to	induce	b-gal	selectively	within	the	relevant	ensemble	90	min	prior	Daun02	
injections.	This	protocol	describes	how	and	when	to	intracranially	infuse	Daun02	to	silence	
the	neuronal	ensembles	of	interest	on	induction	day.	It	is	highly	advisable	to	perform	pilot	
experiments	to	see	if	the	target	brain	area	expresses	b-gal	and	characterize	the	degree	of	
neuronal	activation	(i.e.	counting	the	number	of	Fos	or	b-gal	expressing	neurons)	during	the	
behavior	of	interest,	to	gain	better	insight	about	the	nature	of	the	neuronal	ensemble	that	
is	recruited.	 
Materials	
Fos-lacZ	rat	with	implanted	guide	cannula	
Daun02	(prepared	from	previous	protocol,	4µg/µL	at	room	temperature)		
Vehicle	(prepared	from	previous	protocol)	
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Flexible	tubing		
Hamilton	syringes	(10µL,	with	30	G	needle)	
Infusion	pump	(Item	702001;	Harvard	Apparatus)	
1. Two	to	three	days	before	induction	day,	use	dummy	injector	needles	that	are	
shorter	than	the	guide	cannula	to	practice	a	sham	infusions	session.	The	purpose	of	
this	step	is	to	habituate	the	animals	to	the	infusion	procedure,	and	to	unclog	the	
cannula	in	preparation	for	injections.	
2. On	induction	day,	prepare	the	Daun02	solution	as	described	in	protocol	2	step	3	for	
a	final	concentration	of	4	µg/µL.	Attach	plastic	tubing	to	2	Hamilton	syringes,	then	
attach	2	injector	needles.	Make	sure	that	the	tubing	and	needles	are	cleaned	first	
with	70%	ethanol,	then	water.	Push	out	excess	water,	and	then	aspirate	10	µL	of	
Daun02	or	vehicle	using	the	Hamilton	syringes.	Then	use	the	pump	to	push	the	
Daun02	or	vehicle	solution	until	it	is	slightly	dripping	from	the	injector	needles.	Wipe	
off	excess	fluid	with	sterile	gauze.		
3. Initiate	the	behavior	or	cue	exposure	to	induce	b-gal	in	activated	neurons.	b-gal	
expression	is	at	peak	level	90	min	after	initiation	of	the	behavioral	test.	Perform	
injections	in	a	quiet	room	because	rats	can	be	extra	sensitive	during	this	time.	Gently	
restrain	the	rat	and	insert	both	injector	needles	into	the	bilateral	cannulas.	Place	the	
rat	in	a	comfortable	cage	with	bedding	while	infusing	0.5	µL	of	Daun02	or	vehicle	at	
a	rate	of	1	µL/min.	Once	the	infusions	are	over,	the	injector	needles	should	remain	in	
the	animal	for	an	additional	1	min.		
To	date,	many	behavioral	studies	have	used	relatively	short	behavioral	tests	(e.g.	15-
30	min)	since	they	utilized	procedures	in	which	extinction	learning	took	place	(e.g.	
lever-pressing	for	a	drug-associated	cue).(Bossert	et	al.,	2011;	Cruz	et	al.,	2014a;	
Fanous	et	al.,	2012)	The	duration	was	kept	short	to	prevent	the	behavior	of	interest	
from	being	fully	extinguished	so	that	the	behavior	could	still	be	observed	on	test	day.	
As	a	general	guideline,	a	minimum	and	maximum	test	duration	of	15	and	30	min	will	
allow	the	behavior	of	interest	to	be	adequately	measured,	while	reducing	the	
likelihood	of	it	being	extinguished.	However,	pilot	experiments	are	recommended	to	
determine	the	ideal	test	duration	that	produces	a	sufficient	level	of	responding	on	the	
Daun02	infusion	day	and	the	final	test	day	for	your	behavior	of	interest.	Finally,	it	is	
important	to	include	proper	control	groups	in	demonstrate	that	Daun02	effects	are	
cue-	or	context-specific.	Usually	these	control	groups	are	exposed	to	stimuli	(e.g.	
novel,	neutral	context)	that	would	likely	activate	a	neuronal	ensemble	distinct	from	
the	neuronal	ensemble	of	interest.	
4. The	behavioral	test	is	performed	3	days	later	to	assess	the	effects	of	Daun02	versus	
vehicle	injections.	Recent	evidence	suggests	that	this	time	point	allows	Daun02	
sufficient	time	to	inactivate	b-gal-expressing	neurons.	Although	we	and	others	
normally	test	the	effects	of	Daun02	three	days	following	its	infusion,	it	may	be	
possible	that	Daun02	is	efficacious	at	time	points	earlier	or	later	than	3	days.	Users	
may	want	to	perform	pilot	experiment	to	examine	whether	this	is	the	case.			
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5. 90-120	min	after	initiating	the	behavioral	test,	users	may	choose	to	transcardially	
perfuse	the	rats	using	4%	paraformaldehyde	for	X-gal	staining	or	
immunohistochemistry	of	brain	sections	to	assess	Daun02-mediated	decreases	of	
activated	neurons	using	X-Gal	staining	of	b-gal	(see	next	protocol)	or	
immunohistochemistry	for	Fos	protein.	Alternatively,	since	Daun02	has	been	shown	
to	permanently	silence	neurons	via	apoptosis,	one	may	also	continue	to	test	the	rats	
on	other	behavioral	tests	to	examine	the	effects	of	this	inactivation.		
BASIC	PROTOCOL	5	
Transcardial	perfusions	for	X-gal	staining	(or	immunohistochemistry	for	b-gal	or	Fos)	
following	the	final	behavioral	test.		
In	previous	Daun02	studies,	the	numbers	of	b-gal-expressing	neurons	were	quantified	
following	the	final	behavioral	test	in	order	to	determine	the	degree	of	inactivation	of	cue-	or	
context-activated	neurons	(Bossert	et	al.,	2011;	Cruz	et	al.,	2014a;	Fanous	et	al.,	2012;	Koya	
et	al.,	2009).	The	protocol	below	describes	how	to	transcardially	perfuse	a	Fos-lacZ	rat	
following	a	behavioral	test	to	prepare	the	brain	tissue	for	X-gal	staining	or	b-gal	(or	Fos)	
immunohistochemistry.	Although	both	types	of	staining	can	be	used	to	detect	changes	in	
the	number	of	strongly	activated	neurons,	the	advantage	of	X-gal	staining	is	that	it	has	a	
very	high	signal	to	noise	ratio.		
Materials	
Peristaltic	pump	attached	to	an	IV	line	with	16	gauge	blunt	end	needles	at	end	(for	rat)	
Paraformaldehyde	(PFA,	for	making	4%	PFA)	(Cat	no.	P6148-1KG,	Sigma)	
Rat	guillotine	(Cat	no.	DCAP,	Kent	Scientific	Corportation)	
Sucrose	(for	making	30%	sucrose	solution	in	PBS)	
10x	PBS	pH	7.4	for	making	(1x	PBS)	(Cat	no.	P5493-1L,	Sigma)	
Sodium	hydroxide	solution	10.0	M	(Cat	no.	72068-100ML,	Sigma)	
Sodium	phosphate	monobasic	monohydrate	(Cat	no.	S9638-25G,	Sigma)	
Sodium	Chloride	(Cat	no.	S7653-1kg,	Sigma)	
Ethylene	glycol-bis	(2-aminoethylether)-N,N,Nʹ,Nʹ-tetraacetic	acid	(EGTA)	(Cat	no.	E3889-
25G)	
Magnesium	chloride	solution,	1.0M	(Cat	no.	M1028-100mL,	Sigma)	
Triton	X-100	(Cat	no.	93443-100mL,	Sigma)	
Potassium	ferricyanide	(III)	K3Fe(CN)6		(Cat	no.	244023-100G,	Sigma)	
Potassium	hexa-cyanoferrate	(II)	trihydrate	K4Fe(CN)6	•	3H2O	(Cat	no.	P3289-100g,	Sigma)	
5-Bromo-4-chloro-3-indolyl-β-D-galactoside	(X-gal)	(Cat	no.,	B71800-1.0,	RPI	corporation)	
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N,N-Dimethylformamide	(DMF)	(Cat	no.,	D4551-250mL,	Sigma)	
Chrome-Alum	coated	glass	slides	(or	any	other	electrostatically	charged	slides,	e.g.	
SuperFrost	Plus	slides	(Catalog	no.	22-037-246,	Fisher	Scientific))	
Corning®	Costar®	cell	culture	plates	6	well,	(Cat	no.	CLS3516-50EA,	Sigma)		
	
Corning®	Netwells®	inserts,	membrane	diam.	24	mm	(Cat	no.	CLS3480-48EA,	Sigma)	
	
Staining	racks	and	handles	(Cat.	No.	70312-24,	70312-25,	Electron	microscopy	services)	
	
6	Staining	dishes	(Cat.	No	70312-20,	Electron	microscopy	services)		
	
CitriSolv™	Solvent	and	Clearing	Agent	(Cat	no.	89426-268,	VWR)	
(In	the	UK	use	Histoclear	III	(Cat	no.	HS-204-1	gal,	AGTC	Bioproducts)	
Fisher	Chemical	Permount™	Mounting	Medium	(Cat	no.	SP15-500,	Fisher)	
(In	the	UK	use	Histomount	(Cat	no.	HS-103-100mL,	AGTC	Bioproducts)	
Incubator	or	waterbath		
Any	anesthetic	that	will	produce	deep	anesthesia	(e.g.	isoflurane	saturated	in	air).	
Protocol	steps	
	 Transcardial	perfusions	
1. Prepare	1x	PBS,	4%	paraformaldehyde	(PFA),	and	30%	sucrose	(in	PBS)	solutions.	
These	should	be	set	up	together	with	the	perfusion	equipment	before	the	behavioral	
testing	begins.	Prepare	approximately	100	of	PBS	and	500	mL	of	4%	PFA	per	rat.		
2. Deeply	anesthetize	the	rat	90-120	min	following	initiation	of	the	behavioral	test.	This	
is	easily	done	by	placing	the	rat	in	a	glass	dessicator	for	90	sec	with	isoflurane	
saturated	in	air.	After	confirming	that	the	animal	is	deeply	anesthetized	by	checking	
for	the	pain	reflex	(e.g.	following	pressure	application	on	the	rear	foot),	use	a	large	
pair	of	scissors	to	cut	horizontally	through	the	skin	and	muscle	of	the	thorax	just	
below	the	xiphoid	process,	which	can	be	identified	by	pressing	your	finger	along	the	
mid-axillary	line.	
As	with	all	perfusions,	try	to	reduce	the	time	between	opening	up	the	rat	and	
perfusing	PBS.	Blood	will	begin	to	clot	if	blood	stops	flowing	and	compromise	
subsequent	labeling	(particularly	immunolabelling)	of	activated	neurons.	It	should	be	
relatively	easy	to	keep	this	time	down	to	2-3	minute	or	less	with	practice.		
3. Using	a	hemostat,	grasp	the	now	exposed	xiphoid	process	and	raise	the	anterior	
body	wall.	Cut	through	the	abdominal	muscles	along	the	inferior	margin	of	the	ribs.	
4. Cut	through	the	diaphragm	along	its	attachment	to	the	ventral	and	lateral	margins	of	
the	rib	cage.	Be	careful	not	to	damage	the	heart	that	lies	above	the	diaphragm.			
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5. Cut	through	the	lateral	part	of	the	rib	cage	on	both	sides	up	to	the	collar	bone.	Use	
the	hemostat	attached	to	the	xiphoid	process	to	retract	the	sternum	towards	the	
rat’s	head.	This	should	provide	a	clear	view	of	the	heart	and	vessels.	The	heart	
should	be	beating	at	this	stage.	Remove	any	connective	tissue	around	the	heart.			
6. Using	small	scissors,	make	a	transverse	cut	through	the	posterior	left	aspect	of	the	
heart	to	open	the	rat’s	left	ventricle	(at	the	vertex	of	the	heart).	While	gently	
clamping	the	heart	using	forceps,	insert	the	perfusion	needle	through	the	opening	in	
the	left	ventricle	into	the	ascending	aorta.	Clamp	the	cannula	in	place	using	a	
hemostat	to	secure	the	position	of	the	needle.	The	hemostat	should	be	clamped	
around	the	heart	tissue	immediately	below	the	descending	aorta.	
7. After	confirming	the	placement	of	the	needle	tip,	make	a	small	incision	in	the	right	
atrium	to	make	an	outlet.	Then	turn	on	the	perfusion	pump	and	perfuse	PBS	into	the	
animal	at	a	flow	rate	of	30	mL/min.	Once	PBS	has	replaced	the	blood	in	the	animal’s	
vascular	system,	and	the	fluid	escaping	the	atrium	is	clear,	then	transfer	the	pump	
input	line	from	the	PBS	to	4%	PFA	solution.	
If	fluid	is	coming	out	of	the	nostrils,	then	reduce	the	rate	of	perfusion.	This	effect	is	
due	to	back	flow	of	perfusion	fluid	into	the	lungs,	and	often	due	to	placement	of	the	
tip	of	the	perfusion	needle	too	low	down	in	the	ventricle	rather	than	in	the	ascending	
aorta.	
8. Once	the	transfer	of	PBS	to	PFA	tubing	is	complete,	begin	pumping	the	4%	PFA	
solution.	As	the	fixative	solution	enters	the	body,	the	body	should	rapidly	begin	to	
stiffen	and	the	rat	will	appear	to	be	shaking	due	to	muscle	contractions.	Perfuse	the	
desired	volume,	turn	off	the	pump	and	remove	the	cannula	from	the	heart.		
9. Clear	the	line	of	4%	PFA,	and	refill	it	with	PBS	again	to	commence	the	next	perfusion.	
Make	sure	all	the	lines	are	clear	of	air	bubbles.		
10. Decapitate	the	rat’s	head	using	a	guillotine.	Remove	the	skin	on	top	of	the	head	and	
expose	the	skull.	Use	Rongeurs	to	remove	small	bits	of	the	skull	around	the	foramen	
magnum,	and	use	scissors	to	make	a	small	incision	around	the	midline	of	the	skull	
around	the	occipital	bone.	Using	the	Rongeurs,	very	carefully	remove	the	occipital,	
parietal,	and	frontal	bones.	Once	the	brain	is	fully	exposed,	remove	the	brain	using	a	
spatula	by	gently	going	underneath	the	brain	and	elevating	the	brainstem	until	the	
optic	nerves	pull	free.	Post-fix	the	brain	by	immersing	it	in	4%	PFA	for	1-4	hours.	
Transfer	the	brain	to	a	small	container	(e.g.	50	ml	conical	tube)	containing	30%	
sucrose	solution	diluted	in	PBS.	The	brains	should	remain	in	this	sucrose	solution	at	
4ºC	until	they	sink	to	the	bottom	(which	may	take	2-3	days).	Brains	may	remain	in	
sucrose	for	up	to	five	days.	Once	sunk,	the	brains	can	be	frozen	in	hammer-crushed	
dry	ice	for	at	least	45	min,	then	wrapped	in	aluminum	foil	(to	prevent	dehydration),	
and	stored	at	-80ºC	overnight	(or	until	further	use).	
It	is	important	not	to	overfix	the	brain	(e.g.	overnight	in	4%	PFA)	as	this	might	
decrease	the	action	of	b-gal	enzyme	and	hence	the	efficacy	of	the	X-gal	staining	
procedure	(that	is	dependent	on	b-gal	enzymatic	activity)	(Ma	et	al.,	2002).	
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11. Mount	the	brain	onto	a	cryostat	and	cut	30-40	µm	brain	sections	in	a	cryostat	and	
collect	the	sections	in	PBS	(with	0.02%	w/v	Sodium	azide)	at	RT.	While	slicing,	pay	
close	attention	to	the	location	of	the	injection	sites	and	make	sure	to	collect	these	
sections.	Sections	may	be	stored	at	4ºC	for	1-2	weeks	or	may	be	used	immediately	
for	X-gal	staining.	Alternatively,	sections	may	be	stored	in	cryopreservant	at	-80ºC	
until	further	use.		
X-gal	histochemistry		
12. Wash	sections	3	x	10	min	in	PBS	using	6-well	plates	and	net	wells.		
13. Incubate	sections	in	X-gal	solution	in	a	6-well	plate	in	an	incubator	(or	1.5	mL	tubes	
in	water	bath	away	from	light)	for	2-3	hours	(or	over	night	if	b-gal	is	to	be	detected	
in	naïve	animals)	at	37ºC	while	gentle	shaking.	
14. Wash	sections	3	x	10	min	in	PBS	
15. Mount	onto	chrom-alum	coated	slides	and	dry	over	night.		
16. Place	slides	in	increasing	concentrations	of	ethanol	(2	min	each	at	70%,	80%,	95%,	
100%,	100%	ethanol,	followed	by	10	min	of	CitriSolv	Solvent	or	Histoclear	clearing	
agent).	Remove	excess	solvent	and	coverslip	using	mounting	medium	(Permount	or	
Histomount).	Allow	the	mounting	medium	to	dry	over	night	before	imaging.		
17. Observe	b-gal	labeling	using	a	bright	field	microscope.	Due	to	the	extremely	low	
background	the	tissue	may	appear	almost	translucent	and	it	might	be	difficult	to	
determine	some	major	anatomical	landmarks	in	X-gal	stained	brained	sections	to	
properly	identify	the	region	of	interest.	This	problem	may	be	overcome	by	1)	
Illuminating	your	sample	using	a	fluorescent	light	source;	2)	Creating	more	contrast	
in	the	section	by	adjusting	the	amount	of	light	coming	in	using	the	iris.	Both	methods	
help	visualize	the	brain	section	by	providing	more	contrast	and	thus	making	major	
anatomical	landmarks	more	visible.	Properly	labeled	nuclei	should	have	a	dark	blue	
appearance	(see	Fig.	3)	In	order	to	determine	Daun02-mediated	decreases	in	
activated	neurons,	count	b-gal-positive	cells	that	are	200-300	µm	around	the	
injection	site	from	2-3	sections	from	Daun02	and	vehicle-injected	animals.		
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REAGENTS	AND	SOLUTIONS	
Use	deionized,	distilled	water	in	all	recipes.		
PCR	mix	
Recipe	for	10	µL:	Add	5.5	µL	of	2x	One	Taq	Mastermix,	1.1	µL	of	5	µM	forward	and	5	µM	
reverse	primers	and	3.4	µL	of	water.		
Transgene-specific	oligos	for	OTTC126		(lacZ	gene):	
Forward	primer	 LacZ	F2538	 GTTGCAGTGCACGGCAGATACACTTGCTGA	
Reverse	primer	 LacZ	R2926	 GCCACTGGTGTGGGCCATAATTCAATTCGC	
	
These	oligos	produce	a	388	base	pair	amplicon	that	was	previously	tested	using	an	
annealing	gradient	that	indicates	good	amplification	between	58ºC	and	68ºC	(ideally	
between	64º	to	68	ºC).	This	allows	the	use	of	the	two-step	PCR	program	described	in	Basic	
Protocol	1.			
4%	(w/v)	Paraformaldehyde	solution	
Recipe	for	1L:	In	800-900	mL	water,	dissolve	4	g	sodium	hydroxide	pellets,	and	then	dissolve	
40	g	of	PFA	(this	might	take	more	than	20	min).	Once	the	PFA	is	dissolved	then	add	sodium	
phosphate	(monobasic)	until	dissolved.	Do	not	neutralize	with	sodium	monophosphate	too	
early	because	PFA	will	not	dissolve	in	neutral	solutions.	Bring	up	to	1	L	with	water.	Then	
filter	the	PFA	using	a	vacuum	or	gravity	filter	to	get	rid	of	any	residual	PFA	granules.	Final	pH	
should	be	about	7.4-7.5.	Store	at	4ºC	for	3-4	days.	This	recipe	avoids	unnecessary	problems	
with	the	unfortunately	common	method	of	heating	solutions	to	60ºC	to	dissolve	PFA	in	
neutral	pH.	PFA	dissolves	easily	in	alkaline	solutions	but	not	in	neutral	solutions.	
30%	(w/v)	sucrose	in	PBS	
Recipe	for	1L:	Dissolve	300	g	of	sucrose	in	600	mL	of	1X	PBS.	Then	bring	up	to	1	L	total	
volume	with	1x	PBS.	Store	at	4ºC	for	3	months.	
20%	Triton	X-100	
Recipe	for	500	mL:	Mix	100	mL	of	Triton	X-100	with	400	mL	of	water.	Triton	X-100	is	very	
viscous	and	will	take	time	to	mix	with	water.	Store	at	room	temperature	for	6	months	(or	at	
4ºC	if	you	observe	any	growth	in	the	solution).	
100	mM	EGTA	
Recipe	for	500	mL:	Add	19	g	EGTA	to	about	200	mL	of	distilled	water	and	add	10	M	NaOH	to	
dissolve.	Then	bring	the	volume	up	to	500	mL	with	water.	Store	at	RT	for	1	year.	
Cryopreservant	
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Recipe	for	1	L:	Add	100	mL	of	10x	PBS	into	400	mL	water.	Then	add	200	mL	glycerol	and	20	
mL	DMSO.	Then	bring	the	volume	up	to	1	L	with	water.	Store	at	4ºC	for	1	year.	
2x	b-gal	buffer	
Recipe	for	1	L:	
-Add	27.6	g	of	NaH2PO4•H2O	to	500	mL	of	distilled	water	(200	mM	final).	Use	10	M	
sodium	hydroxide	solution	(about	few	mL)	to	bring	pH	to	7.4.		
-Once	dissolved	add	11.7	g	of	sodium	chloride	(200	mM	final).		
-Then	add	100	mL	of	100	mM	EGTA	solution,	followed	by	4	mL	of	1.0	M	magnesium	
chloride	solution	(final	concentration	4	mM),	and	then	add	20	mL	of	20%	Triton	X-
100.	
-Bring	the	volume	up	to	1	L	with	water.	Final	pH	should	be	7.4-7.5.	Store	at	RT	for	1	
year.	
Note:	The	pH	of	this	stock	solution	buffer	is	critical	to	successful	X-gal	staining.	If	the	
pH	is	out	of	this	range,	the	X-gal	staining	may	not	work.	Make	sure	that	the	pH	meter	
is	calibrated	properly.		
X-gal	solution	
Recipe	for	100mL,	mix	the	following:	
-50	mL	of	2x	b-gal	buffer.	
-2.5	mL	of	200	mM	K3Fe(CN)6		(0.165	g	of	K3Fe(CN)6	in	2.5	mL	water)		
-2.5	mL	of	200	mM	K4Fe(CN)6	•	3H2O	(0.211	g	of	K4Fe(CN)6	in	2.5	mL	water)		
-2.0	mL	of	50	mg/mL	X-gal	dissolved	in	dimethyl	formamide	(DMF)	(100	mg	X-gal	in	2	
mL	DMF)		
-43	mL	of	water	
This	makes	a	solution	with	final	concentrations	of:		
2.4	mM	X-gal	
100	mM	sodium	phosphate	
100	mM	sodium	chloride	
5	mM	EGTA	
2	mM	MgCl2	
0.2%	Triton	X-100	
5	mM	K3Fe(CN)6	
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5	mM	K4Fe(CN)6	
Store	away	from	light	at	4	ºC	for	3-4	days	or	at	-20	ºC	for	1	year.		
Note:	The	final	solution	should	have	a	yellowish	color.	Make	sure	to	use	DMF	compatible	
tubes	(opaque	plastic).		
COMMENTARY	
Background	Information	
For	many	years	neuroscientists	have	hypothesized	that	neuronal	ensembles	activated	
during	a	particular	behavior	played	a	direct	role	in	mediating	that	behavior.	However,	
techniques	such	as	lesioning	or	pharmacological	neuronal	inactivation	of	whole	brain	areas	
or	cell	types	lacked	the	ability	to	selectively	silence	only	the	behaviorally	activated	neurons.	
Daun02	inactivation	allows	us	to	determine	whether	Fos-expressing	neuronal	ensembles	are	
necessary	for	many	types	of	learned	and	motivated	behaviors	that	are	controlled	by	specific	
stimuli	(typically	conditioned	stimuli	that	are	associated	with	salient	events	such	as	drug-
taking).		
In	many	Daun02	studies	performed	so	far,	rats	undergo	behavioral	training	to	associate	two	
distinct	sets	of	stimuli	(e.g.	drug	reward	and	drug	context	‘A’)	via	operant	learning,	such	as	
lever	pressing	for	a	drug	in	a	specific	context	(Bossert	et	al.,	2011;	Cruz	et	al.,	2014a).	After	
several	conditioning	sessions,	the	rats	form	a	learned	association	(e.g.	drug	and	drug	
context),	and	it	is	thought	that	this	association	is	stored	in	neuronal	ensembles	in	various	
brain	areas	(Cruz	et	al.,	2013).	On	‘induction	day’,	some	day	following	the	last	training	
session,	the	rats	are	exposed	to	the	conditioned	stimulus	(e.g.	drug-associated	context	‘A’)	
to	activate	a	neuronal	ensemble	that	encodes	the	learned	association	and	modulates	the	
associated	behavior	(e.g.	drug-seeking)	(see	overview	in	Fig.	2).	Daun02	is	injected	into	the	
brain	area	of	interest	to	silence	this	ensemble	90-120	min	after	ensemble	activation,	and	
then	3	days	later	on	‘test	day’	the	effects	of	Daun02	inactivation	are	examined	by	re-testing	
the	animals	for	the	same	behavior	that	was	observed	on	induction	day.	We	have	previously	
tested	the	idea	that	repeated	presentations	of	the	same	stimuli	activate	the	same	neuronal	
ensemble	(Bossert	et	al.,	2011;	Cruz	et	al.,	2014a;	Fanous	et	al.,	2012;	Koya	et	al.,	2009).	For	
example,	if	the	rat	is	tested	three	days	later	by	presenting	the	same	stimulus	as	on	induction	
day	(e.g.	drug-associated	context	A),	then	the	associated	behavior	is	disrupted.	However,	if	
Daun02	was	injected	following	presentation	of	stimuli	that	was	unrelated	to	the	training	
context	(e.g.	a	saline-associated	context	B	or	a	novel	context	C),	then	drug	seeking	is	not	
disrupted	during	testing	in	the	drug-paired	context	A.	This	latter	result	indicates	that	
Daun02	silenced	a	neuronal	ensemble	that	is	distinct	from	the	neuronal	ensemble	that	was	
activated	by	the	drug-paired	context	A.	This	latter	context	or	cue	control	is	critical	for	
demonstrating	ensemble-specific	inactivation	and	its	effects	on	behavior.	If	this	control	for	
context	or	cue	specificity	is	not	included,	then	the	effects	of	Daun02	inactivation	on	
behavior	cannot	be	distinguished	from	non-specific	global	inactivation	methods	such	as	
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muscimol-baclofen	or	kainic	acid.	Of	note,	a	novel	context	C	often	induces	very	high	levels	
of	Fos	or	b-gal	expression	in	neurons	unrelated	to	context	A,	which	makes	it	a	good	control	
for	demonstrating	that	it	is	the	specific	pattern	of	neurons	that	mediate	behavior,	and	not	
the	number	of	Fos	or	b-gal-expressing	neurons.	(Cruz	et	al.,	2014a;	Fanous	et	al.,	2012) 
Overall,	Daun02	inactivation	experiments	require:	1)	breeding	sufficient	numbers	of	Fos-
lacZ	rats,	2)	b-gal	expression	in	the	brain	area	of	interest	following	the	behavior	of	interest,	
3)	successful	guide	cannula	placement	and	Daun02	injections	on	‘induction	day’,	4)	re-
testing	of	the	animals	for	altered	behavior	on	‘test	day’.	A	general	overview	of	the	Daun02	
experimental	timeline	is	shown	in	Figure	2.			
Breeding	Fos-lacZ	rats		
As	previously	mentioned,	Fos-lacZ	rats	have	been	bred	onto	a	Sprague-Dawley	genetic	
background	strain.	However	it	is	possible	to	backcross	these	Fos-lacZ	rats	onto	different	
strains	(e.g	Long-Evans	or	Wistar).	Using	a	conventional	backcrossing	procedure,	it	will	take	
approximately	2.5	years	to	breed	the	Fos-lacZ	transgene	the	required	10	generations	onto	a	
different	strain.	Companies	such	as	Charles	River	may	assist	with	‘speed	congenics’	services	
that	require	less	time	(1.5	years)	to	reach	the	same	degree	of	congenicity.	In	practice,	due	
to	the	extensive	time	it	takes	to	generate	a	congenic	animal,	many	researchers	simply	
backcross	for	a	few	generations	and	utilize	animals	that	are	more	than	<90%	genetically	
identical	to	the	strain	of	interest.	It	is	critical	in	these	situations	that	pilot	experiments	are	
performed	in	order	to	assess	whether	these	backcrossed	animals	phenotypically	(e.g.	on	a	
behavioral	level)	resemble	the	strain	of	interest.	
Describing	the	many	different	breeding	protocols	is	beyond	the	scope	of	this	protocol,	and	
one	may	want	to	consult	or	leave	this	task	to	a	breeding	specialist	at	the	animal	unit	in	one’s	
institute.	But	in	short,	a	male	or	female	that	is	heterozygous	for	the	Fos-lacZ	gene	is	crossed	
with	an	outbred	wild-type	male	or	female.	Usually,	50%	of	the	offspring	(males	and	females)	
are	heterozygous	for	the	transgene,	where	as	50%	are	not.	If	studies	are	performed	on	only	
one	sex,	then	only	25%	of	the	offspring	are	useable	for	the	Daun02	studies.	As	with	all	
transgenic	breeding	procedures,	excellent	recordkeeping	of	the	positive	and	negative	
offspring	is	crucial.	Ideally,	a	specialist	should	manage	the	colony,	genotyping,	sorting	
positive	and	negative	offspring,	and	record	keeping,	as	these	tasks	become	rather	time-
consuming	when	the	colony	sizes	grow.		
Critical	Parameters		
Designing	the	Daun02	experiment	
Since	Daun02	silences	b-gal-expressing	neurons,	it	is	critical	to	check	if	the	brain	area(s)	of	
interest	expresses	b-gal	in	the	Fos-lacZ	rats.	We	and	others	have	observed	that	b-gal	
labeling	is	very	weak	or	non-existent	in	many	thalamic	nuclei	in	Fos-lacZ	rats,	and	these	
areas	are	not	suitable	for	Daun02	inactivation	(unpublished	observations).	To	date,	many	
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researchers	have	successfully	used	Daun02	in	the	prefrontal	cortex	and	the	striatum	
(Bossert	et	al.,	2011;	Cruz	et	al.,	2014a;	Koya	et	al.,	2009;	Pfarr	et	al.,	2015).	We	have	not	
tested	this	method	in	other	brain	areas	that	express	high	levels	of	b-gal	such	as	the	
hippocampus	or	basolateral	and	central	amygdala.			
When	designing	the	behavioral	experiments	it	is	important	to	include	two	main	groups.	In	
the	first	group,	the	aim	is	to	induce	b-gal	using	a	‘known’	stimulus	(to	induce	the	behavior	of	
interest)	to	silence	the	neuronal	ensemble	of	interest.		For	the	second	group,	the	aim	is	to	
induce	b-gal	in	a	different	neuronal	ensemble	using	a	stimulus	with	different	properties	(e.g.	
visual,	auditory)	than	the	‘known’	stimulus.	Using	these	groups	will	allow	one	to	determine	
whether	the	same	stimulus	repeatedly	activates	the	same	neuronal	ensemble,	and	to	
determine	whether	distinct	sets	of	stimuli	activate	different	sets	of	ensembles.		
Troubleshooting	
X-gal	staining	
X-gal	staining	of	brain	tissue	is	easily	influenced	by	the	pH	of	the	b-gal	buffer,	and	hence	it	is	
important	the	pH	probe	is	working	optimally	and/or	the	pH	meter	is	properly	calibrated.	If	
the	pH	is	incorrect	(especially	if	it	is	acidic),	then	it	is	possible	to	see	blue-stained	blood	
vessels	(possibly	reflecting	conversion	of	X-gal	by	mammalian	b-gal	in	vessels)	with	little	to	
no	staining	of	b-gal-positive	neurons.	If	blood	vessel	staining	is	observed,	then	remake	the	
b-gal	buffer.	One	can	also	use	immunohistochemistry	for	Fos	or	b-gal	protein	expression.	
Exclusion	of	animals	from	study	
Although	it	is	rare,	PCR-based	genotyping	may	produce	false	positives,	i.e.	a	Fos-lacZ-
negative	animals	may	be	labeled	genotype-positive.	In	such	cases,	Daun02	will	have	no	
effect.	Fortunately,	these	animals	can	be	excluded	by	performing	a	X-gal	stain	or	via	b-gal	
immunohistochemistry.	Also,	as	with	any	intracranial	injection	procedure,	a	small	minority	
of	injection	sites	may	contain	necrotic	tissue.	These	animals	should	also	be	excluded.		
Breeding	pairs	are	not	producing	any	transgene	positive	offspring	
In	such	cases,	re-genotype	the	transgene	positive	parent,	and	cull	this	animal	if	it	turns	out	
to	be	transgene	negative.	However,	usually	such	cases	can	be	avoided	by	taking	two	or	
more	tissue	samples	and	checking	to	see	if	there’s	consistency	in	the	PCR	results.		
Anticipated	Results	
If	Daun02	has	silenced	the	neuronal	ensemble	of	interest,	then	on	‘test	day’	the	associated	
behavior	of	interest	will	be	altered	compared	to	animals	injected	with	vehicle	or	another	
group	injected	with	Daun02	following	exposure	to	a	stimulus	that	should	not	activate	the	
neuronal	ensemble	of	interest	(e.g.	novel	cue).	If	there	is	no	Daun02-mediated	behavioral	
alteration,	there	are	several	possibilities:		1)	The	neuronal	ensemble	in	question	does	not	
directly	mediate	the	behavior,	but	it	could	still	play	a	general	modulatory	role	(e.g.	arousal)	
in	the	behavior.	2)	Several	neuronal	ensembles	can	exist	in	the	brain	that	encode	the	
learned	association,	and	inactivation	of	only	one	of	these	ensembles	may	leave	the	behavior	
largely	intact.			
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Time	Considerations	
A	considerable	amount	of	time	is	required	for	breeding	the	Fos-lacZ	rat	colony.	Each	
breeding	cycle	will	take	about	15	weeks	for	rats.	This	time	frame	includes	time	to	reach	
sexual	maturity	(8-12	weeks),	gestation	period	(3	weeks).	Rats	can	be	weaned	usually	at	3	
weeks	old,	but	for	the	purposes	of	implanting	guide	cannula,	rats	should	be	approximately	
16	weeks	old	for	their	skulls	to	be	thick	enough	to	properly	hold	the	cannulae.	Also,	the	
animals	should	recover	for	a	week	post-surgery.	Thus,	users	should	consider	these	time	
periods	when	planning	experiments.		
It	would	be	advisable	to	consider	about	4-6	months	until	a	usable	size	colony	is	obtained.	
Also,	a	typical	Daun02	experiment	may	require	n=18-20	per	group	for	4	groups.	As	with	all	
experiments	requiring	cannula,	it	is	likely	that	15-20%	of	animals	will	be	excluded	due	to	
injection	sites	falling	out	of	the	target	area.	Our	previous	experience	informs	us	that	
completion	of	a	typical	behavioral	experiment	with	a	2x2	factorial	design	(e.g.,	test	and	
control	cues	X	Daun02	or	vehicle)	may	easily	take	up	to	1	to	1.5	years	including	breeding,	
surgeries,	conducting	behavioral	experiments,	performing	X-gal	staining,	etc.	Of	course,	this	
process	may	be	sped	up	if	the	size	of	the	breeding	colony	is	expanded	and/or	multiple	
people	simultaneously	perform	the	surgeries	and	behavioral	experiments.		
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INTERNET	RESOURCES	
Helpful	tips	on	tissue	biopsy	for	genotyping		
http://oacu.od.nih.gov/ARAC/documents/Rodent_Genotyping.pdf		
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FIGURE	LEGENDS	
Figure	1.	Daun02-mediated	selective	inactivation	of	behaviorally	activated	neurons	A)	Fos-
lacZ	rat	neurons	express	β-gal	when	activated.	After	Daun02	is	locally	injected	in	the	target	
brain	area,	β-gal	converts	Daun02	into	its	active	form,	daunorubicin,	which	persistently	
reduces	neuronal	excitability	and/or	lesions	neurons.	B)	Selective	inactivation	of	
behaviorally-activated	neurons	following	Daun02	application.	
Figure	2.	A	general	overview	of	the	experimental	procedures	beginning	with	breeding	the	
Fos-lacZ	animals	and	finishing	with	behavioral	testing.			
Figure	3.	Diagram	of	skull	surface	indicating	the	position	of	the	fissures,	bregma,	lambda,	
and	potential	bone	screw	positions.	Figure	modified	from	(Assi,	2013).	
Figure	4.	X-gal	staining	of	Fos-lacZ	rat	brain.	Note	the	dark	blue	β-gal	expressing	nuclei	(red	
arrows).		
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